# Real-World Cohort Study of Semaglutide in Adults with Type 2 Diabetes Using an Electronic Health Records Database in Tianjin, China.

> PubMed lists PMID 41848818 in Diabetes therapy : research, treatment and education of diabetes and related disorders as Journal Article, with publication-date metadata of 2026-03-18 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41848818-semaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-08-13
- Source checked: 2026-08-13
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41848818-semaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41848818-semaglutide-v1.json
- Content SHA-256: `ec953ccc3fc03df64c4124b22b6efeceef0cf3b33ae54ad621a522dbfb520fde`

## Claims and source pins

### Headline

Real-World Cohort Study of Semaglutide in Adults with Type 2 Diabetes Using an Electronic Health Records Database in Tianjin, China. ([`pubmed-observation-pmid-41848818-2026-08-13-7e136182a1c9`](#source-pubmed-observation-pmid-41848818-2026-08-13-7e136182a1c9))

### Summary

PubMed lists PMID 41848818 in Diabetes therapy : research, treatment and education of diabetes and related disorders as Journal Article, with publication-date metadata of 2026-03-18 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41848818-2026-08-13-7e136182a1c9`](#source-pubmed-observation-pmid-41848818-2026-08-13-7e136182a1c9))

### Paragraph 1

PubMed lists PMID 41848818 in Diabetes therapy : research, treatment and education of diabetes and related disorders as Journal Article, with publication-date metadata of 2026-03-18 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41848818-2026-08-13-7e136182a1c9`](#source-pubmed-observation-pmid-41848818-2026-08-13-7e136182a1c9))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41848818-2026-08-13-7e136182a1c9`](#source-pubmed-observation-pmid-41848818-2026-08-13-7e136182a1c9))

## Sources

<a id="source-pubmed-observation-pmid-41848818-2026-08-13-7e136182a1c9"></a>
- **Real-World Cohort Study of Semaglutide in Adults with Type 2 Diabetes Using an Electronic Health Records Database in Tianjin, China. · retained source version 1:2026-08-13:current:7e136182a1c9156a58d76ce0729d7a8c8312299eb1b72582609eea98f9738b39** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41848818/) (`pubmed-observation-pmid-41848818-2026-08-13-7e136182a1c9`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Real-World Cohort Study of Semaglutide in Adults with Type 2 Diabetes Using an Electronic Health Records Database in Tianjin, China." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41848818-semaglutide-v1.json SHA-256: ec953ccc3fc03df64c4124b22b6efeceef0cf3b33ae54ad621a522dbfb520fde.